Support Last year, pharmaceutical manufacturers significantly increased the amount of money they spent promoting new drugs, which they do mainly by sending sales representatives to visit physicians in their offices. ████████ ███ █████ ███ █████ ███ ██ ███████ ██ ███ ████ ██████ ███ ███████████████ ███████ ████ ████ ████ ██████ ████ ██ ████ ██ ███ ██████████ █████████ ████ ████ ████ ██████████████████ ██████ ██████████ ████ ███████ ██ ███████ ██████ ██ ██████████████ █████ ████████████████
The author hypothesizes that the additional promotion made physicians less willing to receive visits by sales representatives. This is based on the fact that after the additional promotion began, the average number of visits to physicians per representative fell from 640 to 501.
The author assumes there’s no other explanation for the drop in average number of visits per representative.
Which one of the following, ██ █████ ████ ███████ ███ █████████
Most pharmaceutical manufacturers █████████ ███ ████ ██ █████ █████ ██████ ██ ████ █████ █████ ███████████████ █████ ██████ ████ ████ ██ ████ ██████████
Physicians who receive ██████ ████ ██████████████ █████ ███████████████ ███████ ██████ ████ ███████ ██ ██████████ ████ ███ ████████████████ ██████████
Most pharmaceutical companies ███ ███ ████████ ███ ██████ ██ █████ ████ █████ █████████ █████ ███████ ███████████ ████████ ████████ ██ ██████████
Most physicians who █████ ██ ███████ █ █████ ████ █ ██████████████ █████ ██████████████ ████ ███ ████ ██████████████ ████ ████ ████ ██████ █ █████ █████
The more visits █ █████████ ████████ ████ █ ██████████████ █████ ███████████████ ███ ████ ██████ ██ ██ ███ ██ ██ █████████ █████ ████ ██ ████ ████████████████ ████████